Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2017-06-14

Clinical Trial Update: Gemcitabine and Hodgkin's Disease Chemotherapy Followed by Peripheral Blood Stem Cell Rescue for Hodgkin's Disease [Phase 2]

View source ↗

Summary

This Phase 2 trial evaluated gemcitabine-based chemotherapy followed by peripheral blood stem cell rescue for Hodgkin lymphoma. Results were posted after comple…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Gemzar (gemcitabine)

Snippet

Sponsor: Stanford University | Conditions: Hodgkin Disease, Hodgkin's Lymphoma | Phase 2 | Status: COMPLETED | Results posted: 2017-06-14